Half-year report · Q2
2931.TEDINET S100WHUR
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥47.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥23.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥200m | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥431m | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥161m | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥909m | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥624m | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥559m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥650m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥326m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥133m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | −¥294m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥69.1bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥73.3bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥72.7bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.4bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥41.1bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.7bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥32.1bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥31.3bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥18.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥20.6bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.7bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.7bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥16m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥514m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.0bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥361m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥485m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥507m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-4.1 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.85 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.47 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 44.3% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.3% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.0% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 35
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥8m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥8m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥790m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥457m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥457m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥114m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥22.7bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥22.7bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥0 |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥2.8bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥7m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥218m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥24.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥24.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥8m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥2.4bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥811m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥306m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥306m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥251m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥22.0bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥22.0bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥242m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥23.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥23.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 661
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -790000000 | JPY |
| Operating income | CurrentYTDDuration | 1636000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-08-08 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第21期中（自 2025年１月１日 至 2025年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ユーグレナ | |
| Company name in english cover page | FilingDateInstant | Euglena Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 出雲 充 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区芝五丁目29番11号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03-3453-4907 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役代表執行役員 Co-CEO 兼 CFiO 若原 智広 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区芝五丁目29番11号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-3453-4907 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役代表執行役員 Co-CEO 兼 CFiO 若原 智広 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E27054 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 29310 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社ユーグレナ | |
| Filer name in english | FilingDateInstant | Euglena Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2025-01-01 | |
| Current period end date | FilingDateInstant | 2025-06-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2025-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2024-01-01 | |
| Comparative period end date | FilingDateInstant | 2024-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2024-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |